Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | LIM domain kinase 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | dual specificity testis specific protein kinase | Get druggable targets OG5_131191 | All targets in OG5_131191 |
Schistosoma mansoni | protein kinase | Get druggable targets OG5_131191 | All targets in OG5_131191 |
Echinococcus granulosus | dual specificity testis-specific protein kinase | Get druggable targets OG5_131191 | All targets in OG5_131191 |
Schistosoma japonicum | ko:K05743 LIM domain kinase 1, putative | Get druggable targets OG5_131191 | All targets in OG5_131191 |
Schistosoma mansoni | protein kinase | Get druggable targets OG5_131191 | All targets in OG5_131191 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | carbonic anhydrase family protein, putative | 0.1007 | 0.3983 | 1 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.0516 | 0.1906 | 0.031 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0298 | 0.0987 | 0.2093 |
Plasmodium falciparum | carbonic anhydrase | 0.0111 | 0.0194 | 1 |
Mycobacterium ulcerans | carbonic anhydrase | 0.1007 | 0.3983 | 0.3983 |
Schistosoma mansoni | protein kinase | 0.0188 | 0.052 | 0.0861 |
Plasmodium vivax | sulfate transporter, putative | 0.0065 | 0 | 0.5 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0298 | 0.0987 | 1 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.194 | 0.7923 | 1 |
Echinococcus multilocularis | dual specificity testis specific protein kinase | 0.0188 | 0.052 | 0.4114 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.0298 | 0.0987 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0298 | 0.0987 | 0.2093 |
Schistosoma mansoni | carbonic anhydrase | 0.1007 | 0.3983 | 1 |
Chlamydia trachomatis | sulfate transporter | 0.0065 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0111 | 0.0194 | 1 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.0962 | 0.379 | 0.3344 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.0298 | 0.0987 | 1 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.0298 | 0.0987 | 1 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.1007 | 0.3983 | 0.5 |
Echinococcus granulosus | carbonic anhydrase II | 0.0298 | 0.0987 | 1 |
Schistosoma mansoni | protein kinase | 0.0188 | 0.052 | 0.0861 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.1007 | 0.3983 | 1 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0298 | 0.0987 | 1 |
Echinococcus granulosus | dual specificity testis-specific protein kinase | 0.0188 | 0.052 | 0.4114 |
Echinococcus multilocularis | carbonic anhydrase II | 0.0298 | 0.0987 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.2431 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.2431 | 1 | 0.5 |
Onchocerca volvulus | Putative sulfate transporter | 0.0407 | 0.1447 | 0.5 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0298 | 0.0987 | 1 |
Onchocerca volvulus | 0.0407 | 0.1447 | 0.5 | |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0298 | 0.0987 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 231 nM | Inhibition of LIMK1 (unknown origin) assessed as remaining ATP level using cofilin-2 protein as substrate measured after 60 mins incubation with enzyme by KinaseGlo assay | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.